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Summary 
The post-genomic era heralds a multitude of challenges for chemists and biologists 
alike, with the study of protein functions at the heart of much research.  The elucidation 
of protein structure, localization, stability, post-translational modifications and protein 
interactions will steadily unveil the role of each protein and its associated biological 
function in the cell.  The push to develop new technologies has necessitated the 
integration of various disciplines in science.  Consequently, the role of chemistry has 
never been so profound in the study of biological processes.  By combining the strengths 
of recombinant DNA technology, protein splicing, organic chemistry and the 
chemoselective chemistry of native chemical ligation, various strategies have been 
successfully developed and applied to chemoselectively label proteins, both in vitro and 
in live cells, with biotin, fluorescent and other small molecule probes.  The site-specific 
incorporation of molecular entities with unique chemical functionalities in proteins has 
many potential applications in chemical and biological studies of proteins.  In this study, 
we present an intein-mediated strategy to generate N-terminal cysteine containing 
proteins both in vitro and in vivo, and its applications in 2 different areas related to 
proteomics and chemical biology, namely protein microarray technologies for large-scale 
protein analysis and live cell bioimaging.  
In the first application for live cell bioimaging, a protein of interest having an N-
terminal cysteine was expressed inside a live cell using intein-mediated protein splicing.  
Our choice of intein meant that no external factors (e.g. proteases) were required for 
splicing, with the splicing activity occurring spontaneously inside the cell and affected 
primarily by the identity of amino acids at the splice junction.  Incubation of the cell with 
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a thioester-containing, cell-permeable small molecule probe allowed the probe to 
efficiently penetrate through the cell membrane into the cell, where the chemoselective 
native chemical ligation reaction occurred between the thioester of the small molecule 
and the N-terminal cysteine of the protein, giving rise to the resulting labeled protein.  
Other endogenous molecules, such as cysteine and cystamine, are present in the cell and 
will also react with the probe.  However, their reaction products are also small molecules 
in nature, and can be easily removed, together with any excessive unreacted probe, by 
extensive washing of the cells after labeling.  This is a simple and elegant approach for 
site-specific labeling of proteins in live cells with minimal modifications to the target 
protein, apart from the introduction of a few extra amino acid residues at the N-terminus 
of the target protein.  We have shown that the strategy may be readily applied to both 
bacterial and mammalian cells with a variety of thioester-containing small molecule 
probes. 
In the second application, N-terminal cysteine-containing proteins generated by the 
same intein-based approach were immobilized onto thioester functionalized glass slides 
to generate a protein microarray.  The N-terminal cysteine residue of the protein reacts 
chemoselectively with the thioester to form a native peptide bond while the presence of 
other reactive amino acid side chains, including internal cysteines, is tolerated in this 
reaction.  We have demonstrated that the site-specific immobilization of proteins 
orientates the proteins in a uniform fashion, allowing the full retention of their biological 
activities. We have also shown that the strategy is extremely versatile, applicable to the 
immobilization of N-terminal cysteine proteins which are either purified prior to spotting, 
or present in crude cell lysates (e.g. unpurified). 
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1. Introduction 
Genetic engineering of inteins and clever manipulations of their unique protein 
splicing chemistry have allowed researchers to developed powerful tools for 
biotechnological applications.  Putting together N-terminal cysteine proteins generated by 
intein-fusion methods with a highly chemoselective chemistry known as native chemical 
ligation, we can site-specifically incorporate molecular entities with unique chemical 
functionalities into proteins.  We have thus identified two important applications in the 
field of chemical biology, namely protein microarrays and bioimaging.  The following 
paragraphs will cover relevant background information on the biological as well as 
chemical aspects of the technologies that we have utilized in this work. 
 
1.1. Inteins and protein splicing 
Inteins and their protein splicing abilities are becoming increasing invaluable tools in 
protein engineering.[1]  Protein splicing is a cellular processing event that occurs post-
translationally at a polypeptide level.  The initial nonfunctional protein precursor 
undergoes a series of intramolecular reactions and rearrangements, resulting in the 
excision of an internal polypeptide fragment, the intein, and the concurrent ligation of the 
two flanking polypeptide sequences, termed the N- and C-exteins.  The product is the 
ligation of the two exteins through a native peptide bond to form a functionally mature 
protein.  Inteins are thus analogues of the well-known self-splicing RNA introns.  The 
first intein was discovered 1987 and more than 100 inteins are listed to date.[2,3]  Inteins 
have been found in organisms from eubacteria, archaea, and eucarya, as well as in viral 
and phage proteins.  They are predominantly found in enzymes involved in DNA 
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replication and repair.  Inteins can be divided into four classes: 1) the maxi inteins, with 
integrated endonuclease domain, 2) mini inteins, lacking the endonuclease domain, 3) 
trans-splicing inteins, where the splicing junctions are not covalently linked and 4) 
Alanine inteins, where alanine is the N-terminal amino acid). 
Protein splicing is an intramolecular process, involving bond rearrangement rather 
than bond cleavage and resynthesis and is catalyzed entirely by the amino acid residues 
contained in the intein.[1]  The biochemical mechanism of protein splicing includes the 
formation of a (thio)ester intermediate and the final step of a N→O or N→S acyl shift to 
form the final amide-linked product.  This extremely complex process is autocatalytic, 
requiring neither cofactors nor auxiliary enzymes.  The elucidation of the splicing 
mechanism and the identification of the key amino acid residues involved in the scission 
and ligation of the peptide bonds have facilitated the molecular engineering of artificial 
inteins as tools for different applications in protein chemistry.  These intein-mediated 
recombinant approaches provide a biological alternative to traditional chemical means for 
protein semi-synthesis of proteins.[4]  This so called “Expressed Protein Ligation” (EPL), 
or intein-mediated protein ligation,[5] has found many applications in biotechnology.  
Briefly, by generating proteins containing either a C-terminal thioester or an N-terminal 
Cys residue using protein expression systems with self-cleavable affinity tags based on 
modified inteins, it is now possible to introduce unnatural functional groups into large 
proteins using semi-synthetic approaches.  Many important proteins have been 
successfully synthesized in vitro, including the 600 amino acid N-terminal segment of the 
σ70 subunit of E. coli RNA polymerase.[6] 
 
Trans-splicing inteins, in which the 
functionally mature inteins are split into two smaller intein pieces, regain their activity 
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upon reconstitution of the fragments.[1]  They have found a variety of applications in 
vitro, including protein semi-synthesis[5, 7]
 
and segmental isotopic labeling.[8]  These split 
inteins have even been used to cyclize proteins in vivo,[9-11] and to study protein-protein 
interactions in living cells.[12, 13]  Indeed, protein trans-splicing has many of the attributes 
necessary for the semi-synthesis of unnatural proteins in vivo.  Recently, Muir et al. 
cleverly adopted the trans-splicing property of the Ssp DnaE intein for the semi-synthesis 
of proteins in live cells,[14] where the specific incorporation of chemical probes into the 
protein was successfully demonstrated possible to introduce unnatural functional groups 
into large proteins using semi-synthetic approaches.  In this study, we take advantage of 
the self-splicing ability of genetically modified inteins coupled with a unique chemical 
reaction described in the following section.  
 
1.2. Native chemical ligation 
Covalent chemical reactions compatible with physiological environments and capable 
of achieving high selectivity have a myriad of applications in biotechnology, biomedical 
research and chemical biology.  For such reactions to work inside complex cellular 
environments, they have to 1) proceed efficiently in aqueous conditions, 2) have 
participating functional groups that are carefully tuned such that their reaction is highly 
specific and devoid of any interference from other chemical entities present in 
surrounding molecules (e.g. proteins, DNA/RNA, etc.) and 3) generate a product which is 
highly stable in its physiological environments.  Very few highly selective and in vivo-
compatible reactions for the in vivo labeling of biomolecules are known to date.[4, 5, 15-19]  
One such reaction is the native chemical ligation. 
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The well-established chemistry of native chemical ligation was first described by 
Dawson et al. in 1994,[15]
 
and recently reviewed,[4] as a general synthetic route for the 
semi-synthesis of native proteins.  While many other ligation chemistries exist which 
result in the formation of a non-native bond at the ligation site of the protein,[16] the 
native chemical ligation is one of the very few non-enzymatic reactions known, which 
efficiently join two unprotected peptide segments, containing appropriately installed 
chemical functionalities, to generate a ligated peptide/protein product having a native 
peptide bond at the reaction site.[15]  This highly chemoselective reaction occurs in an 
aqueous solution at physiological pH and involves a peptide fragment with an N-terminal 
Cys residue and a second peptide fragment containing a C-terminal thioester group.  The 
essence of the native chemical ligation reaction lies in the trans-thioesterification step 
between the thioester in one peptide and the sulfydryl group from the N-terminal Cys 
residue in the other to generate a ligated thioester intermediate, which then undergoes 
spontaneous S→N acyl rearrangement to give rise to the final ligated product containing 
a native peptide bond at the ligation junction (Fig. 2A).  The first-step trans-
thioesterification reaction is catalyzed by a suitable thiol additive, and is reversible under 
physiological conditions.  The subsequent intramolecular nucleophilic attack by the α-
amino group of the N-terminal Cys to form the final amide bond is irreversible, and 
highly favorable due to the intramolecular five-member ring formation.  Consequently, 
all of the freely equilibrating thioester intermediates (i.e. from the first-step reaction) will 
eventually be depleted by the irreversible second-step reaction, giving rise to only a 
single stable, ligated product.  A key feature of this reaction is that it is highly 
chemoselective – the reaction occurs exclusively at the N-terminal Cys of the peptide, 
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One potential application of the above described biotechniques is in bioimaging, a 
field that is still in its stages of infancy but is currently seeing rapid development.  
Studying the dynamic movement and interactions of proteins inside living cells is critical 
for a better understanding of cellular mechanisms and functions.  Traditionally this has 
been done by in vitro labeling of proteins with fluorescent and other molecular probes, 
followed by monitoring them inside live cells.  Recent advances in genetic engineering 
have made it possible to directly generate fluorescent proteins in living cells or even in 
live animals by fusion of fluorescent proteins such as GFP (green fluorescent protein) to 
the protein of interest.[20-22]  GFP and its variants, some of which possessing enhanced 
fluorescent properties, improved pH-resistance etc., have been of late, a popular choice 
for tracking protein movement and interactions.[22]  However, the main drawbacks of 
GFP-like proteins include their large sizes (e.g. 27 kDa for GFP), obligate 
oligomerization which may affect the native biological activity of the fused protein, and 
sometimes slow or incomplete maturation.  In addition, relatively few “colors” are 
available amongst existing fluorescent proteins and they are not always ideal 
fluorophores, as many have broad excitation/emission spectra, low quantum yields and 
are susceptible to photobleaching.  Lastly, the use of fluorescent proteins limits protein 
labeling to only fluorescent and not any other molecular tags (e.g. biotin).  
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A good labeling strategy should ideally satisfy the following criteria: 1) a high signal-
to-noise ratio (i.e. high specificity for target protein); 2) uphold the integrity of the 
labeled protein; 3) non-interference with the biochemical functions or cellular 
localization of the labeled protein and 4) have minimal perturbation of cellular 
processes.[20, 21]   
Chemical methods for live cell labeling with a plethora of novel fluorescent labels, 
many of which are much smaller and chemically tailored to specifically label proteins are 
a promising alternative to fluorescent proteins.  Numerous novel strategies for specific 
labeling of proteins with small molecular probes in live cells have recently been 
reported.[23-30]  Each strategy is based on well-known chemistries and bio-interactions.  
Cell permeability, non-toxicity, specific reactivity, good fluorescent properties, should be 
carefully noted during the design and tailoring of small molecule probes.  Compared to 
the fluorescent proteins like GFP, small molecule probes possess a myriad of advantages 
including the above as well as a wide spectral color.  Their small size ensures minimal 
perturbation of protein function other cellular components, which makes them attractive 
over fluorescent proteins.  
One of the first strategies for site-specific labeling of recombinant protein with small 
organic molecules within live cells was developed by Tsien’s group.[23, 24]  This method 
exploits the high affinity of organoarsenicals with pairs of thiols.  A tetracysteine motif, 
CCXXCC (in which X is a non-cysteine amino acid) was genetically fused to the protein 
and labeled with biarsenical probes.  Their utility in live cell imaging was demonstrated 
in visualizing the translocation of connexin in and out of gap junctions.[25]  Non-covalent 
interactions of small molecule ligands with streptavidin- and antibody-conjugated fusions 
 7  
have also been used for in vivo labeling of proteins.[26, 27]  Johnsson et al. described an 
enzymatic approach to label proteins fused to the human O6-alkylguanine-DNA 
alkyltransferase (hAGT) with small molecular substrates as probes.[28]  A recent report of 
small molecule probes for live cell labeling was based on the noncovalent interaction 
between E. coli dihydrofolate reductase (DHFR) and methotrexate (Mtx) conjugates.[29]  
Vogel et al. reported a generic method for the site-selective and reversible labeling of 
membrane proteins containing a polyhistidine sequence in live cells with small organic 
fluorophores conjugated to a metal ion (e.g. Ni2+) chelating nitrilotriacetate (NTA) 
moiety.[30]  The labeling is based on the well-known interaction between polyhistidine 
sequences and the Ni2+-NTA moiety.[31]  This fast and reversible approach was 
successfully applied to determine the topology of the membrane proteins in living cells 
and is suitable for studying the protein-protein interactions within cellular signaling.  
The above methods provide a site-specific means to label proteins in vivo, with 
relatively fast reaction rates, with labeling being both covalent irreversible and 
noncovalent reversible. Each strategy, however, possess their own inherent 
disadvantages.  For example, hAGT and DHFR are both full-length proteins (21 kDa and 
18 kDa respectively) required for fusion to the target protein, while the biarsenical 
labeling requires addition of high amounts of dithiols additive (micromolar range) to 
reduce the background signal.[23-25]  The main disadvantage of fluorescent NTA probes is 
that direct visualization is not possible with a His6 tag and had to be indirectly inferred 
from FRET (fluorescence resonance energy transfer) data due to the relatively low 
affinity of the interaction (1-10µM).  The affinity of the interaction improved with 10 
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histidines (~200nM), and although shown to be give a better signal-to-noise ratio for 
detection, is still probably not as high as one would desire.[30] 
 
1.4. Protein microarrays 
The second application of this work is in the bludgeoning field of microarrays, in 
which protein microarrays hold great promise.  In the post-genomic era, the primary aim 
for researchers around the world is to fully characterize and understand all proteins 
encoded by the genome, or the so-called “proteome”.[32]  Over the past few years, a 
variety of proteomic techniques have been developed, allowing many thousands of 
proteins to be studied based on either their relative abundance,[33] or their enzymatic 
activities.[34]  Most of these technologies, however, are based on the traditional protein 
separation technique, the 2-dimensional gel electrophoresis, which requires downstream 
instrumentations such as mass spectrometry in order to identify the proteins of interest 
individually.  They are therefore time-consuming and not easily automatable.  Newer 
technologies, especially those based on microarray platforms, have the potential to 
rapidly profile the entire proteome, thus are capable of revealing novel protein functions 
and mapping out comprehensive protein interaction networks of an organism.[34]  The 
very first report on microarray technologies was credited to Fodor and coworkers in 
1991.[35]  This novel idea demonstrated the feasibility of simultaneously generating 
thousands of µm- size spots on a small glass slide, leading to potential miniaturization and 
high-throughput screenings of biological assays.  In 1999, MacBeath and Schreiber,[36] 
generated a high-density microarray of proteins and peptides in a 3” x 1” area using an 
automatic robotic spotter.[37]  Their seminal work, although conceptually simple and 
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primitive by today’s standard, has inspired the rapid development of many other types of 
related technologies in the subsequent years.[38-48]   
 
1.4.1. Immobilization strategies 
The miniaturization of high-throughput screening on a single microscope-sized glass 
slide has the undeniable advantage of needing only minute quantities of expensive 
reagents for most biological assays.  Nevertheless, the challenges when dealing with 
proteins are numerous and complex.  Proteins, in general being polymers of amino acids 
and possessing immense chemical, physical and structural diversity, present additional 
problems when immobilized in a microarray.  They require intricate manipulation and 
care to ensure preservation of features such as spot uniformity, stable immobilization and 
preservation of desired protein activity in a microarray.[34]   
The immobilization of biomolecules onto a glass surface while maintaining their 
native properties is a critical area where researchers focus on generating different 
chemical surfaces on a plain glass, allowing efficient protein/peptide immobilization 
using appropriately chosen functional groups present on these biomolecules.  For most 
biological assays to be successfully carried out in a microarray, it is crucial that 
immobilized proteins and peptides are oriented on the glass surface in an active state and 
with a high density.  Traditional surfaces used for protein/peptide immobilization in a 
standard biochemical assay, including polystyrene, poly-vinylidene fluoride (PVDF), 
agarose thin film and nitrocellulose membranes, could not be adopted easily in a 
microarray format, primarily because these surfaces use non-covalent forces (e.g. 
hydrophobic interactions) for immobilization, resulting in the generation of low-density 
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arrays of biomolecules which are randomly oriented on the surface.  As a consequence, 
these surfaces often give rise to relatively low signal-to-noise ratios in downstream 
protein/peptide screening assays.  Glass slides, however, have the ideal surface for 
microarray applications because they are inexpensive and with low intrinsic fluorescence, 
at the same time also possessing a relatively homogeneous chemical surface, which, 
when used with appropriate bioconjugate chemistry, are capable of immobilizing 
biomolecules at very high densities. This directly translates into highly sensitive detection 
of proteins/peptides in most microarray assays.  
The surface of the glass slide is usually derivatized with chemicals to generate 
different types of molecular layers.  Immobilization of proteins/peptides is then 
subsequently carried out either by covalent linkage or non-covalent adsorption.  One of 
the most crucial disadvantages of non-specific adsorption is insufficient exposure of 
functional domains, largely due to a variety of unpredictable orientations the immobilized 
peptides/proteins can adopt upon binding to the glass surface.  This often results in 
binding of an unnecessary fraction of biomolecules with improper orientation, thus 
impeding their binding with ligands and subsequent downstream biological assays. 
Another possible drawback is that noncovalent binding by hydrophobic interaction may 
cause protein denaturation and the loss of its functional activity.  The molecules 
immobilized on the array may also be vulnerable to further manipulation, which may 
result in the graduate depletion of proteins adsorbed noncovalently.   
In order to ensure that all biomolecules are functionally active, it is imperative that 
they are aligned uniformly and optimally upon immobilization onto the glass surface. A 
variety of immobilization techniques have therefore been developed in the past few years 
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which allow site-specific immobilization of different molecules.  These involve various 
chemoselective chemistries including the oxime/thiazolidine formation,[38] the Diels-
Alder reaction,[39, 40] the Staudinger ligation,[41] the α-oxo semicarbone ligation.[42]  Zhu 
and Snyder were the first to successfully spot 6000 yeast proteins onto a single glass slide 
to generate the so-called “proteome array”.[43]  Their work was made possible by 
introducing site-specific immobilization of their proteins, which are all (His)6-tagged, 
onto a glass slide functionalized with Ni-NTA.  Our group developed two strategies for 
site-specific immobilization of peptides using the high affinity biotin-avidin interaction 
and native chemical ligation.[44]  The use of the biotin-avidin interaction has recently been 
extended by our group to the specific immobilization of proteins in a microarray format, 
while preserving the proteins’ function and integrity.[45-48] 
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1.5. Objectives  
1.5.1. Site-specific protein labeling with small molecule probes for bioimaging 
applications 
We propose a novel bioimaging strategy using intein-mediated splicing and small 
molecule probes to specifically label live cells.[40, 41]  We have recombinantly engineered 
N-terminal Cys containing proteins at the C-terminus of the Ssp DnaB mini intein 
(17kDa) using the pTWIN vector (NEB, USA).  Intein-mediated cleavage occurs 
between the last amino acid of the mini intein and the first residue (i.e. cysteine) of the 
target protein (Fig. 1).  Incubation of the cell with a thioester-containing, cell-permeable 
small molecule probe (Fig. 2C) allows the probe to efficiently penetrate through the cell 
membrane into the cell, where the chemoselective native chemical ligation reaction 
occurs between the thioester of the small molecule and the N-terminal Cys of the protein, 
giving rise to the resulting labeled protein (Fig. 2A & B).[49, 50]  The presence of other 
reactive amino acid side chains, including internal cysteines, is tolerated.[15]  The intein-
mediated approach requires no external factors (e.g. proteases)[51] or addition of thiols, 
with the splicing activity affected primarily by the identity of amino acids at the splice 
junction, pH and temperature.[52, 53] 
Our strategy provides an elegant and simple approach for the site-specific labeling of 
proteins in live cells with minimal modifications to the target protein.  We first showed 
that the strategy could be applied to the specific labeling of proteins in vitro, followed by 
labeling of proteins expressed inside live bacterial cells.  We then further demonstrate the 
generality and versatility of our approach for bioimaging by extending it to site-specific, 
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in vivo labeling of proteins expressed inside live mammalian cells, which are 






















Figure 1. Mechanism of intein splicing at the C-terminal junction of the Ssp DnaB intein, 
with Asn as the last amino acid of the intein and Cys as the first residue of the target 
protein. Self-cleavage can be induced by a shift in temperature and pH conditions and 
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Figure 2. Site-specific protein labeling strategy with small molecule probes. A) 
Chemoselective native chemical ligation between an N-terminal cysteine in a protein and 
a thioester-containing probe, forming a stable amide bond. B) Strategy for site-specific 
covalent labeling of N-terminal cysteine proteins and thioester probes in live cells. C) 
Structures of cell-permeable, thioester probes. D) Fluorescence spectra of probes CM 
(blue), FL (green), TMR (orange) and CF (red). Excitation and emission spectra are 





1.5.2. Site-specific immobilization strategy for protein microarray 
Exploiting the same intein-mediated expression system and the chemoselective 
chemistry of native chemical ligation reaction, N-terminal Cys proteins were site-
specifically immobilized on thioester functionalized glass slides (Fig. 3).  Previous work 
in our group had established the specific immobilization of N-terminal Cys kinase 
peptide substrates in a proof-of-concept experiment.[36]  We extend the strategy to 
immobilization of proteins in a microarray format, demonstrating in the process that site-
specific immobilization of proteins allowed the full retention of their biological 
activities.[39]  This strategy is extremely versatile, applicable to the immobilization of N-
terminal Cys proteins which are either purified prior to spotting, or present in crude cell 
lysates (i.e. unpurified).  

























Figure 3. Intein-mediated strategy for the site-specific protein immobilization to generate 
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2. Materials and Methods 
2.1. Construction of expression plasmids 
EGFP and GST were PCR amplified from pEGFP (Clontech, USA) and pGEX-4T1 
(Pharmacia Biotech, USA) respectively, and cloned into the pTWIN1 and 2 expression 
vectors (NEB, USA) respectively.  Similarly, ECFP with a nuclear localization sequence 
(NLS) was amplified from pECFP-Nus (Clontech, USA) and cloned into pTWIN1 
vector.  The 3 genes were inserted in frame after the C-terminal of the Ssp DnaB intein 
(Intein1) in the pTWIN1 and pTWIN2 vectors, with the first amino acid of the protein of 
interest engineered to be a cysteine residue.  This was achieved by cloning the target gene 
between the first Sap I site of the vector and the Pst I site.  The latter is found after 
Intein2 tag (Mxe GyrA) and the 2nd chitin-binding domain (CBD).  Upon ligation of the 
gene to the vector, the Pst I site is regenerated while the Sap I site is lost.  The Sap I site 
allows for the insertion of a cysteine residue (codon TGC) after the last amino acid of the 
intein, asparginine (codon AAC).  Upon intein cleavage, the target protein will have an 
N-terminal Cys.   Figure 4 illustrates the cloning strategy. The resulting constructs are 
pTWIN1-EGFP and pTWIN2-GST and pTWIN1-ECFP-NLS.   







         
      CAC    AAC TGC AGA GCC --- tac aag taa CTG CA                  G GAA   
      GTG TTG             ACG TCT CGG --- atg ttc  ATT G              AC GTC CTT 
    
 
 
Figure 4. Cloning of a target gene into the Sap I and Pst I sites of the pTWIN vector. The 
target gene sequence is in lower case letters. Following digestion of the vector and PCR 
products by endonucleases Sap I and Pst I, the insert and vector can then be ligated.  
 
 
PCR mixtures (total volume 100µl) were prepared as follows: 10µl 10x Deep Vent 
DNA polymerase buffer (NEB, USA), 0.2mM of each dNTPs (Promega), 1mM of each 
primer, 100ng plasmid DNA template, 2 units Deep Vent DNA polymerase (NEB, USA).  
Amplification was carried out in a DNA EngineTM thermal cycler (MJ Research, USA).  
Cycling conditions are described as follows: denaturation at 94°C for 1min, annealing at 
61°C for 1min and extension at 72°C for 1min for a total of 30 cycles.  PCR products 
were sequentially digested, first with the restriction enzyme Sap I (NEB, USA) and then 
using Pst I (NEB, USA).  The pTWIN vector was digested similarly and purified using a 
gel extraction kit (Qiagen).  Overnight ligation at 16°C was performed using an 
T7 promoter 
CBD Intein1 MCS CBD Intein2
Target gene
SapI Pst I 
Sap I Pst I Target gene
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approximate “vector” : “insert” ration of 1:8 using a T4 ligase (NEB, USA).  
Transformation of the ligated products into E.coli ER2566 (NEB, USA) was done by the 
heat shock method and PCR colony screening was performed to determine the presence 
of the “inserts”.  All constructs were sequencing using the ABI PRISM BigDyeTM 
Terminator v3.0 to confirm the identity of the first amino acid cysteine of the target 
protein as well as the rest of the protein sequence.  
For the mammalian constructs, the intein-fused EGFP and intein-fused ECFP-NLS 
genes were amplified from pTWIN1-EGFP and pTWIN1-ECFP-NLS respectively.  
Using the GATEWAYTM cloning system (Invitrogen, USA), the intein-fused genes were 
cloned into the donor vector pDONR201, followed by recombination of the cloned genes 
into a mammalian expression vector pT-Rex-DEST30.  The resulting mammalian 





The primers used for the following constructs are listed as follows: 
pTWIN1-EGFP  
5’-GGT GGT TGC TCT TCC AAC TGC AGA GCC atg gtg agc aag ggc- 3’          
5’-GGT GGT CTG CAG tta ctt gta cag ctc gtc-3’ 
pTWIN2-GST 
5’-GGT GGT TGC TCT TCC AAC TGC AGA GCC atg tcc cct ata cta- 3’      
5’-GGT GGT CTG CAG tca gtc acg atg cgg-3’ 
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pT-Rex-DEST30-intein/EGFP 
5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTC GAA GGA GAT AGA 
ACC ATG GCT ATC TCT GGC GAT AGT-3’ 
5’-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC CTG CAG tta ctt gta cag-3’ 
pTWIN1-ECFP-NLS and pT-Rex-DEST30-intein/ECFP-NLS 
5’-GGT GGT CTG CAG tta tct aga tcc ggt gga-3’ 
5’-GGGG AC CAC TTT GTA CAA GAA AGC TGG GTC CTG CAG tta tct aga tcc-3’ 
 
2.2. Protein expression and purification 
Transformed E.coli ER2566 host cells were grown in 1L of LB medium containing 
100mg/L ampicillin at 37°C in a 250rpm air shaker.  Protein expression was induced at 
an OD600 ~ 0.6 with 0.5mM IPTG (isopropyl-β-D-thiogalactoside) and left shaking 
overnight at room temperature.  Cells were harvested by centrifugation (5000 x g, 30min, 
4°C), resuspended in lysis buffer (20mM Tris-HCl pH 8.5, 500mM NaCl, 1mM EDTA) 
and lysed by sonication (ultrasonic liquid processor model XL 2020) on ice.  The cell 
debris was pelleted down by centrifugation (4000 x g, 30min, 4°C) to give a clear lysate 
containing the intein-fusion proteins. 
The column was packed with 10ml of chitin beads (column volume) and pre-
equilibrated with 5 column volumes of column buffer (20mM Tris-HCl pH 8.5, 500mM 
NaCl, 1mM EDTA).  The clear cell lysate was then loaded onto the column at a flow rate 
of 0.5ml/min and washed with at least 10 volumes of column buffer at a flow rate of 
2ml/min.  The column was then flushed quickly with one column volume of cleavage 
buffer (20mM Tris-HCl pH 7.0, 500mM NaCl, 1mM EDTA) to distribute it evenly 
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throughout the resin before stopping the flow.  The above procedures were carried out at 
4°C to prevent premature on-column cleavage of intein-tag.  On-column incubation with 
the cleavage buffer took place for 20h at room temperature with gentle agitation and the 
protein was eluted with 20ml of column buffer collected in 2ml fractions.  The first 10 
fractions of purified protein were pooled together, lyophilized and then desalted through 
a NAP-5 column (Amersham Pharmacia, USA).  Each step of the purification was 
analyzed by 12% SDS-PAGE and the identity of eluted proteins were confirmed by 
Western blotting with anti-GST (Santa Cruz Biotechnology, USA), anti-EGFP (Clontech, 
USA) and anti-CBD (Santa Cruz Biotechnology, USA). 
 
2.3. Small molecule probes 
A total of 6 different probes (Fig. 2C) were synthesized as described elsewhere.[49]  
CM, FL, TMR and CF are fluorophore-containing thioesters, BIOTIN is a biotin-
containing thioester probe, while C2FL is a “caged” molecule of FL, in which the 
fluorescence is designed to be “turned on” selectively upon photolysis.  All probes were 
designed to be cell-permeable, in that acetates of different fluorophores were 
incorporated in CM, FL and CF to increase their cell permeability.  The fluorophore in 
TMR, as well as the biotin moiety in BIOTIN, were previously shown to be cell-
permeable.[59]  Addition of the hydrophobic, benzyl-based thioester in all probes should 
further increase their cell permeability.  CM, FL, TMR and CF containing different 
fluorophores (i.e. coumarin (CM), fluorescein (FL), tetramethylrhodamine (TMR) and 
carboxynaphthofluorescein (CF), respectively) that emit in different colors (i.e. blue, 
green, orange/yellow and red, respectively; see Fig. 2D), were designed for potential 
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multicolor cell labeling and imaging.  Proteins labeled with BIOTIN may be used to 
study protein-protein interactions by in vivo experiments utilizing biotin-avidin binding. 
Probe C2FL may be used for protein labeling in a live cell where temporal and/or 
confined fluorescence activation is needed. 
 
2.4. In vitro labeling  
Purified N-terminal Cys EGFP was incubated for up to 24 hours with probes FL, 
TMR, CF and BIOTIN in order to assess our labeling strategy.  Probes were prepared as 
200 µM stocks (25 x in DMSO) and stored at -20oC.  In a typical labeling reaction, 6 µl 
of each probe (final concentration: 8 µM) was added to 50 µl of pure protein (1 mg/ml) 
dissolved in 1 x PBS (final concentration of protein: ~2 nM), and the reaction was topped 
up with 1 x PBS to a final volume of 150 µl.  At specific time intervals, 15 µl of the 
reaction was withdrawn and quenched by addition of 1.7 µl of 100 mM cysteine to the 
reaction mixture (final concentration of cysteine: 10 mM), followed by denaturation with 
SDS-PAGE loading dye at 95ºC for 3 min.  The loading dye also serves to hydrolyze the 
diacetates groups on FL and CF, thereby releasing the fluorescence.  Upon separation 
with a 12% SDS-PAGE gel, the fluorescence labeling of EGFP by FL, TMR and CF 
was conveniently visualized by scanning the resulting gel with a Typhoon™ 9200 
fluorescence scanner (Amersham Biosciences, USA).  Fluorescence intensity of each 
protein band was analyzed using the software, Image Quant 5.2, preinstalled on the 
instrument.  For the labeling of EGFP with BIOTIN, an anti-biotin western blot was 
performed to visualize the amount of biotinylated EGFP.  Briefly, following SDS-PAGE 
separation, the resulting gel was electroblotted onto a PVDF membrane (BioRad, USA) 
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and blocked for 1 h with 5% non-fat dry milk in PBST (phosphate buffered saline, pH 7.4 
with 0.1% Tween 20).  The membrane was incubated with anti biotin-conjugated HRP 
(NEB, USA) in a 1:1000 dilution in milk-PBST for 1 h and then washed with PBST (3 x 
15 min).  Visualization was done using the ECL™ kit (Amersham).  
The specific covalent nature of the labeling reaction was confirmed by repeating the 
experiment under identical conditions with 5 negative control proteins which do not 
possess N-terminal Cys residue, but may have only internal cysteines (e.g. papain, GST).   
 
2.5. In vivo labeling in bacteria    
Bacterial constructs transformed into the E.coli expression strain ER2566 (NEB) 
were grown in 100 mg/L ampicillin containing LB media at 37°C.  At OD600 = ~ 0.6, 0.3 
mM of IPTG was added, and the cells were further grown for 18 h at room temperature to 
induce the fusion protein expression, as well as for the fusion protein to undergo 
sufficient self-cleavage and generate the desired N-terminal cysteine protein in vivo.  To 
label the protein in live cells, 20 µM of the probe (5-100 µM also worked) was added 
directly to the LB media containing grown cells, and incubated for 24 h.  For the time-
course labeling experiments, a small sample of cells was removed at each time interval, 
quenched with 0.01 M cysteine and lysed by boiling with SDS loading buffer.  The 
resulting sample was analyzed directly on a 12% SDS-PAGE.  Fluorescence labeling was 
visualized with a Typhoon fluorescence scanner (Amersham Biosciences).  
Biotinylated proteins were detected by western blotting as described above.   
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2.6. Protein expression and in vivo labeling in mammalian cells    
HEK293 cells were grown in Dulbecco’s modified Eagle’s medium (DMEM, Sigma) 
supplemented with 10% fetal bovine serum (Biological Industries, USA), penicillin (100 
units/ml) and streptomycin (100 µg/ml) at 37°C with 5% CO2.  Cells were seeded at 2.4 x 
106 cells per 100 mm tissue culture plate.  After overnight incubation, cells were 
transiently transfected with the pT-Rex-DEST30-intein-EGFP/ECFP-NLS using PolyFect 
Transfection Reagent (Qiagen, USA).  After at least 24 hours of protein expression, cells 
were washed in 1x PBS and cystine-free DMEM (Sigma) was added.  The biotin-
thioester probe, BIOTIN, was added to a final concentration of 100 µM and cells were 
incubated for another 24 h.  Cells were harvested by centrifugation at 1000 rpm for 10 
min and resuspended in 1x PBS.  Washings were repeated at least 3 times, and cells were 
lysed in PBS using glass beads (Sigma).  Streptavidin MagneSphere® Paramagnetic 
Particles (Promega, USA) were used to pull-down all biotinylated proteins in the cell 
lysate.  Protein samples were incubated with excess streptavidin magnetic beads for 1 h at 
4oC to ensure all biotinylated proteins were absorbed onto the beads.  Beads were then 
washed thrice in 1x PBS, then boiled in 1x SDS loading buffer and loaded onto a 12% 
SDS-PAGE.  Western blotting was used to assess biotinylated proteins, as described 
above.  For the quantification of in vivo labeling efficiency, a streptavidin absorption 
experiment was carried out to separate biotinylated proteins from non-biotinylated ones.  
Sample fractions bound to the streptavidin beads and from the flow-through were 
analyzed by both anti-biotin and anti-EGFP western blotting.  
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2.7. Probe-toxicity assay   
A stock solution of 5mM BIOTIN dissolved in DMSO was used for all experiments.  
HEK293 cells transfected with ECFP-NLS were labeled with BIOTIN at concentrations 
of 100uM, 200uM, 500uM, 1000uM and 2000uM for 24h.  “Blank” experiments adding 
only DMSO to the respective final concentrations were also performed simultaneously.  
Cells were stained with 0.04% trypsin blue and counted using a haemocytometer.  The 
percentage of cell death from the BIOTIN experiments was subtracted from the 
respective “blank” experiments to obtain the final percentage of cell death for a particular 
BIOTIN concentration.  All experiments were performed in triplicates and the average 
values plotted. 
 
2.8. Fluorescence microscopy   
For bacteria, labeled cells were harvested by centrifugation at 4000 rpm for 10 min.  
Upon resuspension in 1x PBS buffer (pH 7.4) containing 10% glycerol, cells were left 
standing for 30 min.  This procedure was repeated 3 times for complete removal of any 
free probes.  Cells were mounted on clean glass slides coated with 1.5% agarose.  
Fluorescence images were recorded with the AxioSkop 40 fluorescence microscope 
(Zeiss, Germany) equipped with a cooled CCD camera (AxioCam, Zeiss) using a 63x or 
100x oil objective.  For HEK293 mammalian cells, following their growth as described 
above to induce protein expression, cells were washed in 1x PBS and cystine-free 
DMEM (Sigma) was added, followed by 100 µM of TMR and 0.01 mM CaCl2.  Upon 
incubation for 24 h, labeled cells were washed thrice with 1x PBS and imaged with the 
AxioVert 2000 fluorescence microscope (Zeiss) equipped with a cooled CCD camera 
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(AxioCam, Zeiss) using a 63x objective.  Different fluorescence images were obtained 
with different excitation/emission filter sets:  Coumarin channel (excitation = 365 nm and 
emission = 420 nm LP); CFP channel (excitation = 436 + 20 nm and emission = 480 + 40 
nm); GFP channel (excitation = 470 + 20 nm and emission = 530 + 25 nm); TMR & Red 
channels (excitation = 546 + 12 nm and emission = 590nm LP).  The FRET channel for 
CFP/TMR pair was recorded using filters with an excitation = 436 + 20 nm and emission 
= 620 + 20 nm (Chroma).  The FRET channel for GFP/TMR pair was recorded using 
filters with excitation = 470 + 20 nm and emission = 605 + 30 nm (Zeiss). 
 
2.9. Protein microarray 
2.9.1. Derivatization of thioester slides  
Glass slides were cleaned in a piranha solution and derivatized with a 1% solution of 
3-glyicidoxypropyltrimethoxisilane (95% ethanol, 16mM acetic acid) for 1h and cured at 
150°C overnight.  The resulting epoxy slides were incubated with 10mM diamine-PEG 
(Shearwater, USA) in 0.1M NaHCO3, pH 9 for 30min.  The slides were then placed in a 
solution of 180mM succinic anhydride in DMF (N,N-dimethylformamide), pH 9 
(Na2B4O7) for 30min and subsequently placed in boiling water for 2min.  The carboxylic 
acid groups were then activated with a solution of 100mM TBTU (N,N,N'-tributyl 
thiourea), 100mM HOBt (1-hydroxy 1H-benzotriazole), 200mM DIEA 
(diisopropylethylamine) and 100mM NHS (N-hydroxysuccinimide) in DMF for 3h and 
reacted overnight with a solution of 120mM DIEA and 100mM benzylmercaptan in 
DMF.  
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2.9.2. Protein immobilization and detection 
The lyophilized N-terminal Cys proteins were dissolved in PBS buffer, pH 7.4 to a 
stock concentration of 1mg/ml.  These were spotted onto the thioester functionalized 
glass slides in various concentrations using an ESI SMATM arrayer (Toronto, Canada).  
For spotting of unpurified protein samples, bacteria cells were harvested after 18h protein 
expression, lysed in 1 X PBS (pH 7.4) and spotted immediately onto thioester slides.  All 
slides were incubated for 3h and subsequently washed with water for 20min.  Slides 
could then be used for detection purposes or stored at 4ºC for a few weeks.   
Anti-EGFP and anti-GST were both labeled with the dye Cy5-NHS (Amersham 
Pharmacia, USA), while glutathione was conjugated with Cy3-NHS (Amersham 
Pharmacia, USA) for 1h in 0.1M NaHCO3, pH 9 according to the manufacturer’s 
protocol and purified through a NAP-5 column (Amersham Pharmacia, USA).  The 
spotted and washed slides were blocked with PBS-glycine (0.5M) for 3h and incubated 
with the fluorescence-conjugated antibodies for 1h and washed with PBST for 15min to 
remove unhybridized antibodies and to reduce background fluorescence.  Glutathione-
Cy3 hybridization was carried out in a similar fashion.  Slides were visualized with an 
ArrayWoRxTM microarray scanner under the corresponding channel: FITC channel 
(emission: 528nm, for native EGFP fluorescence), Cy3 channel (emission: 595nm) and 
Cy5 channel (emission: 685nm).  Relative spot intensities were analyzed with the 
ArrayWoRxTM software by subtracting the background intensity from the total spot 
intensity.   
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3. Results and Discussion 
3.1. One-step affinity column cleavage and purification 
The Ssp DnaB intein-mediated strategy was originally designed to generate and 
purify N-terminal Cys proteins in a single-step.[53]  The approach is direct and eliminates 
the need for extra steps (e.g. the use of additional proteases)[51] or extra reagents (e.g. the 
addition of thiols during cleavage),[52] all of which could serve to further complicate the 
purification process.  In order to obtain pure N-terminal Cys proteins, it is necessary to 
obtain the uncleaved CBD-intein-fusion intact for binding onto a chitin column and 
subsequent in vitro cleavage of the target protein via the intein self-splicing mechanism 
under selected conditions.  We have established that performing protein expression at 
room temperature for 12h, substantial quantities of the fusion precursor (at least 50%) 
could be harvested for chitin column affinity protein purification and cleavage, and 
sufficient quantities of purified target protein obtained.  Upon cell lysis, in vitro cleavage 
of the fusion protein was minimized by carrying out on-column loading and washings in 
lysis buffer (pH 8.5) and at 4°C.  On-column cleavage and purification conditions were 
optimized by incubating the bound fraction at in cleavage buffer (pH 7.0) and room 
temperature for 12h.  Figure 5 summarizes the entire protein expression and purification 
process as monitored by 12% SDS-PAGE (Coomassie stain).  Despite the loss of proteins 
during the purification and cleavage process through spontaneous in vivo cleavage (lane 2 
in Fig. 5) and unspecific binding of target protein to the chitin beads (lane 6 in Fig. 5), a 
final yield of 1.5mg/L purified N-terminal Cys EGFP was obtained.   









   


















Figure 5. Expression and purification of N-terminal Cys EGFP by in vitro intein-
mediated cleavage on a chitin affinity column. Lane 1: Cell lysate before induction with 
IPTG. Lane 2: Overexpression of CBD-intein-EGFP fusion protein (~50 kDa) after 
induction. Some amount of in vivo cleavage is observed (27 kDa EGFP and 23 kDa 
CBD-intein). Lanes 3-5: The first 3 fractions from the elution (2ml each). Lane 6: Chitin 
beads after elution boiled in SDS-loading buffer. Lane M: Protein molecular weight 
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3.2. Site-specific covalent labeling of N-terminal Cys proteins for Bioimaging 
3.2.1. In vitro labeling 
To first determine the feasibility of our labeling strategy for eventual bioimaging 
applications, in vitro labeling of purified proteins containing an N-terminal Cys together 
with negative controls of pure proteins not possessing an N-terminal Cys was carried out.  
The specificity and time dependency of the labeling process was monitored.  Affinity 
column purified EGFP containing an N-terminal Cys was used as a model and was 
incubated with probes FL, TMR, CF and BIOTIN separately.  The extent of protein 
labeling was monitored over 24 hours by SDS-PAGE and Western blotting (Fig. 6).  
Labeled proteins were visualized and quantitated, either by a fluorescence gel scanner (in 
the cases of FL, TMR and CF) or Western blotting using anti-biotin HRP conjugate (in 
the case of BIOTIN).  In all cases, the labeling was determined by the intensity of each 
fluorescent band and shown to reach near completion (> 75% labeling) within the first 3 
hours of the reaction (Fig. 7).  In addition, more than 50% labeling occurred within the 
first 30 min of the reaction, making this strategy suitable for potential real-time 
bioimaging experiments in live cells.  The site-specific nature of the labeling reaction was 
confirmed by repeating the experiment under identical conditions with control proteins 
which do not have an N-terminal Cys, but some of which containing internal cysteines 
residues (Fig. 8).  Labeling occurred ONLY with proteins possessing an N-terminal Cys, 
thereby supporting the original design principle, in which exclusive labeling should only 
occur at the N-terminal Cys of the target protein.  This is in agreement with a previous 
report that N-terminal Cys proteins generated by a protease-mediated selective protein 
cleavage method, could be specifically labeled in vitro by thioester-containing 
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molecules.[51]  We have further characterized this chemoselective reaction in vitro and 
will attempt to extend the strategy to labeling live cells in vivo for bioimaging 























Fig. 6. SDS-PAGE of purified N-terminal Cys EGFP labeled with A) TMR, B) FL and 
C) CF followed by visualization with a TyphoonTM 9200 fluorescence gel scanner; and 
D) BIOTIN followed by Western blot with anti biotin-conjugated HRP. Lanes 1 to 8 (left 


































Figure 7. % completion of EGFP labeling over a 24-hour interval with FL (blue 
diamonds), TMR (purple squares), CF (yellow triangles) and BIOTIN (red diamonds). 
Fluorescence intensity of each protein band was analyzed using the software, Image 
Quant 5.2, preinstalled on the Typhoon™ 9200 fluorescence scanner (Amersham 















Figure 8. Control labeling reactions of 5 commercially available proteins not containing 
an N-terminal Cys. FL was used in the labeling reaction, and the reaction was performed 
as mentioned above with 60 min incubation time. All proteins are available from Sigma 
(St Louis, USA). Lane 1. GST (cat #: G-4385); 2. Subtilisin (P-5380); 3. Lipase (L-
9031); 4. Papain (P-4762), a cysteine protease; 5. Pepsin (P-6887); M. BioRad Precision 
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3.2.2. Expression & in vivo cleavage of intein-fusion proteins to generate N-
terminal Cys proteins in bacteria and mammalian cells  
As discussed in 3.1, the Ssp DnaB intein-fusion system was designed for in vitro 
affinity column intein-mediated cleavage and protein purification.[53]  This meant cell 
growth and purification conditions which minimized the in vivo cleavage of the fusion 
protein, so as to allow the on-column isolation of the entire fusion protein (e.g. intein-
target protein) before in vitro cleavage of the target protein.  However, we observed with 
great interest, that a substantial amount of the fusion protein always underwent 
spontaneous in vivo cleavage under standard cell growth conditions (i.e. pH 7 cell media 
at 37oC or room temperature), leading to the release of the intein-cleaved target protein 
inside growing cells.  We then capitalized on this phenomenon to generate, in vivo, N-
terminal Cys-containing proteins.  The N-terminal Cys proteins could subsequently be 
labeled site-specifically in vivo with thioester-containing small molecule probes through 
the chemoselective reaction known as native chemical ligation.   
E. coli transformed with pTWIN2-GST constructs were used as a model to optimize 
cell growth conditions such that maximum intein-mediated protein cleavage occurred in 
vivo to generate GST possessing an N-terminal Cys residue.  It was determined that in a 
bacterial system, protein expression at room temperature for 18h was sufficient to cleave 
~ 50% GST from its intein fusion (Fig. 9A).  The in vivo cleavage of EGFP and ECFP-
NLS, transiently expressed in HEK293 cells from pT-Rex-DEST30-intein-EGFP and pT-
Rex-DEST30-intein-ECFP-NLS respectively, were next examined.  Both EGFP and 
ECFP were engineered to possess an N-terminal Cys residue upon cleavage from the 
intein fusion.  In addition, the pT-Rex-DEST30-intein-ECFP-NLS construct, having a 
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nuclear localization sequence (NLS) attached to the C-terminus of intein-ECFP fusion, 
allowed in vivo cleavage of the intein fusion inside the nucleus to be assessed.  As shown 
in Figure 9B and 9C, both EGFP and ECFP were efficiently cleaved (estimated > 90% 
cleavage for intein-EGFP and > 60% for intein-ECFP-NLS) after 48h of transient 
expression, indicating that intein-mediated, in vivo protein cleavage could occur 
efficiently in different cellular compartments inside mammalian cells.  Western blot was 
necessary to follow the in vivo cleavage in mammalian cells as transfection efficiencies 
are never 100% and protein expression in mammalian cells is typically lower.  
Other methods for generating recombinant proteins possessing N-terminal Cys 
residues, including the use of methionyl aminopeptidases,[54] the ubiquitin-fusion 
strategy[55] or selective proteolysis with highly specific proteases like the TEV (tobacco 
etch virus) protease,[42] may potentially be used with our labeling strategy.  This intein-
mediated approach was selected however, because it requires no external factors (e.g. 
proteases) or addition of thiols.  The cleavage activity is affected primarily by the identity 
of amino acids at the splice junction,[52] and further in vivo cleavage can be potentially 
increased by modifying residues at the +2 position on the extein (i.e. after the +1 cysteine 



























Figure 9.  In vivo cleavage efficiency of intein-fused proteins in different organisms. A) 
In bacteria, in vivo cleavage of intein-GST fusion protein occurs at about 50% as seen by 
coomassie stain (left) and anti-GST western blot (right). B) and C) Western blots (with 
anti-EGFP antibody) of in vivo cleavage of intein fusion proteins in HEK293 mammalian 
cells: estimated > 90% in vivo cleavage for intein-EGFP as shown in B), and > 60% in 
vivo cleavage for intein-ECFP-NLS as shown in C). Note that anti-EGFP antibody 
detects both EGFP and ECFP.  
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3.2.3. In vivo labeling in bacteria 
Having established that intein-mediated protein cleavage occurred efficiently inside 
both bacterial and mammalian living cells and that the probes specifically labeled N-
terminal Cys proteins in vitro, in vivo labeling of live cells with the cell-permeable probes 
were then tested.  Other endogenous molecules, such as cysteine and cystamine, are 
present in the cell and will also react with the probe.  However, we believe that as their 
reaction products are also small molecules in nature, they can be easily removed, together 
with any excessive unreacted probe, by extensive washing of the cells after labeling. 
To label the N-terminal Cys-containing GST overexpressed in bacteria, probes (5-100 
µM) were directly added to the growing cells in media after in vivo protein cleavage was 
induced, followed by incubation for 0-24 h for the labeling reaction to occur.  At the end 
of the labeling, excess probes and side products (e.g. probes conjugated to free cysteine) 
were removed by extensive washings of the cells.  For quantification of time-dependent 
in vivo labeling, a small sample of the labeled cells was periodically analyzed by SDS-
PAGE (Fig. 10A).  Specific in vivo labeling was shown to occur in a time-dependent 
fashion, consistent with that for in vitro labeling, with > 50% of the labeled protein 
observed within the first 3 h of labeling (Fig. 10B).  
Due to the intrinsic reactivity of thioester towards any thiol-containing molecules, it 
is possible that the probes may react with internal cysteines of a protein, generating a 
“mis-labeled” protein in which internal cysteines in the protein are thiol-esterified by the 
probe via a thiol exchange reaction.  However, it is hypothesized that this “thiol-
acylation” reaction is readily reversed inside living cells by aqueous hydrolysis to 
spontaneously release the unlabeled protein.  Consequently, of all proteins present in the 
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cell, only those possessing an N-terminal Cys may be stably and irreversibly labeled by 
our probes.  In order to unambiguously confirm this, N-terminal Cys-containing GST was 
expressed and labeled in vivo, followed by direct analysis of the whole-cell protein 
content using a DTT-free SDS loading buffer (lane 1 in Fig. 11).  Lysis and denaturation 
using a DTT-free loading buffer prior to SDS-PAGE separation prevents additional 
hydrolysis through sample preparation and allows the detection of any protein which may 
have been “mis-labeled” at its internal cysteine thiols.[46, 52]  As shown in Figure 11, the 
major fluorescent band observed in DTT-free SDS loading buffer (lane 1) corresponds, 
both in intensity and molecular weight, to that of the target protein when DTT was 
present (lane 2).  It is noted that some faint background bands which are observed in lane 
1 and not present in lane 2 (* in Fig. 11) could have arisen from the acylated internal 
cysteines proteins or could have been just a fluorescence artifact.  In spite of this, it is 
postulated that background labelings are tolerable for bioimaging experiments, and they 
may be reduced further by more extensive washings of the labeled cells.  Taken together, 
these results confirm the specific covalent nature of our strategy, which allow for in vivo 
labeling of N-terminal Cys-containing proteins with high efficiency and low background.  























Figure 10. In vivo labeling of bacterial cells. A) Time-course labeling of cells expressing 
N-terminal Cys-containing GST with i) FL, ii) TMR and iii) BIOTIN. Labeled cells 
after specified time intervals were analyzed on a 12% SDS-PAGE (left to right): 0 min, 
10 min, 30 min, 1 h, 3 h, 6 h, 12 h & 24 h. B) % completion of GST labeling over 24-
hour intervals with FL (♦), TMR () and BIOTIN (c).  
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Figure 11. Specific in vivo labeling of N-terminal Cys-containing GST with 10 µM 
TMR. Fluorescence image (left) of the whole cell lysate (Coomassie stain, right) is 
shown side-by-side. Cells in lanes 1 were lysed in DTT-free SDS-loading buffer, while 
those in lane 2 were lysed in regular SDS-loading buffer containing DTT. The 27 kDa 
GST band in lane 1 appeared smeared due to the lack of reducing agent (i.e. DTT) in the 
SDS-loading buffer. A small amount of background bands (indicated by *) in lane 1 
which disappeared in lane 2 may be from other “mis-labeled” proteins.  
 
 
3.2.4. Fluorescence microscopy of bacteria cells labeled with different probes 
We next demonstrated the versatility of the strategy by labeling live bacterial cells 
with probes having different fluorescence spectra and other chemical properties.  E. coli 
cells overexpressing an N-terminal Cys GST protein were treated with TMR, and the 
site-specific labeling of the probe inside the cells was assessed by fluorescence 
microscopy: exclusive labeling occurred only with E. coli cells overexpressing N-
terminal Cys GST (Fig. 12A).  Similarly, bacterial cells expressing N-terminal Cys GST 
were labeled with CM, FL and CF, giving rise to cells that have different “colors” (Fig. 
12Bii, iii, iv).  Cells overexpressing GST without an N-terminal Cys when treated with 
TMR for 24h showed no fluorescence in the TMR channel, demonstrating that the N-
terminal Cys of the protein is indeed the crucial factor necessary for the labeling strategy 
(Fig. 12Bi).  When labeled with C2FL, the “caged” analog of FL, labeled proteins inside 
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the cell could be selectively “lighted” up by UV photolysis (Fig. 12C), indicating the 
potential of this approach for a variety of other advanced bioimaging techniques.[56]  With 
BIOTIN, labeled proteins may be used for in vivo studies of protein-protein interactions 
by pull-down experiments.[57]  
The spectra overlap of EGFP (emission maxima at 520nm) and the probe TMR 
(excitation maxima at 550nm) in our labeling strategy provides an ideal donor-acceptor 
pair for fluorescence resonance energy transfer (FRET).  FRET occurs if one fluorophore 
has an emission spectrum that overlaps significantly with the absorption spectrum of a 
second fluorophore, and if the two fluorophores are physically very close to each other 
(generally between 1 and 6nm (the Forster distance)), then energy from the first (donor) 
molecule may be transferred to the second (acceptor) molecule.[56]  This is a non-radiative 
phenomenon (no photons are emitted from the donor) in which energy from the donor 
(shorter wavelength emission) fluorophore is transferred to the acceptor (longer 
wavelength emission) fluorophore.  When this happens, the donor fluorophore’s 
fluorescence is quenched (reduced in total light output).  The acceptor’s emission is 
triggered by energy absorbance or transfer from the donor and results in a wavelength 
appropriate emission from the acceptor.  This transfer is exquisitely distance sensitive, 
and as accidental FRET is an extremely rare event (effectively never happening) it is a 
reliable indicator of molecular interaction.[48]  As the probe TMR is attached covalently 
to the N-terminus of EGFP, the close distance between the two fluorophores allows for 
efficient FRET, which would serve to confirm this specific covalent labeling strategy of 
N-terminal Cys proteins with small molecule probes inside live cells.  As shown in 
Figure 13A, a clear FRET signal is observed in all TMR-labeled bacterial cells 
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expressing N-terminal Cys-containing EGFP, indicating the specific covalent nature of 
the labeling.  Also evident in Figure 13A is that, neither TMR nor FRET signals could be 
detected in those cells not expressing EGFP, further demonstrating that the labeling 
strategy only works when there is an N-terminal Cys-containing protein present inside the 
cell.  A negative control of unlabeled cells expressing EGFP revealed no fluorescence in 
both the TMR and FRET channel even with extended exposure time (Fig. 13B).  
 

















Figure 12. Fluorescence microscopy of live bacteria after labeling. A) E. coli expressing 
N-terminal Cys GST after labeling with TMR for 24 h. The fluorescence image (TMR 
channel) was overlapped with the phase contrast image for easy visualization. B) N-
terminal Cys GST-expressing cells labeled with other probes: i. fluorescence microscopy 
image (TMR channel) of negative control with cells not expressing N-terminal Cys GST 
but labeled with TMR (inset: phase contrast image); ii. fluorescence microscopy image 
(Coumarin channel) of GST-expressing cells labeled with CM; iii. fluorescence 
microscopy image (GFP channel) of GST-expressing cells labeled with FL; iv. 
fluorescence microscopy image (Red channel) of GST-expressing cells labeled with CF. 
All cells were labeled for 24 h. Scale bar is 2 µm. C) N-terminal Cys GST-expressing 
cells labeled with C2FL: i. fluorescence microscopy image (GFP channel) after 0 min 
UV photolysis (inset: phase contrast image); ii. fluorescence microscopy image (GFP 
channel) after 5 min UV photolysis. Scale bar is 2 µm. 
























Figure 13. A) FRET analysis of N-terminal Cys EGFP-expressing cells labeled with 
TMR: i. overlay of phase contrast image with fluorescence microscopy image in GFP 
channel; ii. overlay of phase contrast image with fluorescence microscopy image in TMR 
channel; iii. FRET channel of the labeled cells (excitation: 470 + 20 nm; emission: 605 + 
30 nm). Note that cells not expressing EGFP (arrowed) showed neither TMR nor FRET 
signal. Scale bar is 1 µm. B) Fluorescence microscopy images of unlabeled bacterial cells 
expressing N-terminal Cys EGFP: i. GFP channel; ii. FRET channel under the same 
exposure conditions as Aiii; (iii) FRET channel with a 10x longer exposure time.  
 
 
3.2.5. In vivo labeling of N-terminal Cys proteins in mammalian cells 
Having successfully demonstrated the strategy for highly specific, covalent protein 
labeling inside bacterial cells, the strategy was next extended to mammalian cells, which 
are more useful for bioimaging applications, yet much more challenging because of their 
cellular complexity.  Intein-fused EGFP and ECFP mammalian expression vectors were 
constructed, in which an extra N-terminal Cys was introduced into both EGFP and ECFP, 
as described in 3.1..  To facilitate evaluation of the labeling, as well as to assess whether 
target proteins expressed in subcellular compartments within mammalian cells (e.g. 
nucleus) could be labeled using this strategy, ECFP was fused to a nuclear localization 
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intein-fused protein occurred efficiently in HEK293 cells, consistently generating > 60% 
cleaved proteins for subsequent labeling experiments.  
To determine the site-specific, covalent nature of the labeling strategy in a 
mammalian system, HEK293 cells transiently transfected with EGFP were incubated 
with the thioester-containing biotin probe, BIOTIN, in cystine-free media, and the in 
vivo labeling of EGFP assessed by SDS-PAGE and western blots of the resulting cell 
lysates (Fig. 14A).  Western blot was necessary to validate the in vivo labeling in 
mammalian cells, as only a small amount of the target protein was expressed due to 
intrinsically low efficiency of the transient transfection and low expression in mammalian 
cells (as compared to bacteria cells).  As shown in Figure 14A, endogenously biotinylated 
proteins, namely methyl-crotonyl-CoA-carboxylase and propionyl-CoA-carboxlyase 
(both 75kDa), were detected in untransfected, unlabeled HEK 293 cells (lane 1).  This is 
consistent with what was reported previously.[46]  Administration of the probe to 
untransfected (lane 2) and transfected cells (lane 3) showed little background labeling on 
the western blot, while a substantial additional band at ~ 27kDa in transfected cells (lane 
3) confirmed covalent labeling of the expressed N-terminal Cys EGFP protein.  This 
validated the feasibility of the strategy in mammalian cells with tolerable background 
labeling.  
The relative efficiency of the in vivo labeling strategy was assessed by streptavidin 
absorption experiments (Fig. 14B & C) with EGFP-expressing HEK293 cells labeled 
with BIOTIN.  After the labeling reaction, cells were extensively washed to remove any 
excessive free probe and lysed in 1XPBS.  The resulting cell lysate was incubated with an 
excess of streptavidin beads to isolate biotinylated proteins (the bead-bound fraction) 
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from non-biotinlyated proteins (the flow-through fraction).  As shown on the western blot 
detected with anti-EGFP antibody in Figure 14B, a comparison of EGFP present in the 
flow-through (lane 1; 1/5 of total volume) and that bound to the beads, it was estimated 
that < 10% of all cleaved EGFP was labeled in vivo.  A separate but duplicate western 
blot was ran simultaneously, using anti-biotin antibody, to ensure the successful 
separation of biotinylated/non-biotinylated proteins in the absorption experiment (Fig. 
14C): almost no biotinylated proteins were detected in the flow-through fraction (lane 1, 
streak is probably due to western blot artifact).  Albeit the relatively low efficiency of the 
labeling, the potential of the strategy for bioimaging applications in bacterial (see 3.2.3. 
and 3.2.4.) and mammalian systems (see also 3.2.6.) can already be previewed.  Work is 
currently underway in the group to improve on the labeling efficiency and kinetics of the 
strategy, including modifying the thioester group on the probe to generate better 
nucleophiles and leaving groups, and examining labeling conditions and possible 
additives during labeling to improve the signal-to-noise ratio. 


























Figure 14. Specific in vivo labeling of N-terminal Cys-containing proteins in HEK293 
mammalian cells. A) EGFP-expressing cells labeled with BIOTIN for 24 h. Shown is the 
western blot (with anti-biotin) of HEK293 cells: lane 1. non-transfected cells; lane 2. 
non-transfected cells labeled with 100 µM of the probe; lane 3. EGFP-transfected cells 
labeled with 100 µM of the probe. Note that a band was observed in all lanes, 
corresponding to endogenously biotinylated methyl-crotonyl-CoA-carboxylase and 
propionyl-CoA-carboxlyase (both 75kDa). B) and C) Determination of percentage in vivo 
labeling in HEK293 cells expressing EGFP using streptavidin absorption experiments. 
The same sample was divided equally and 2 separate Western blots using B) anti-EGFP 
and C) anti-biotin were carried out. In lanes 2, biotinylated proteins were pulled-down 
using streptavidin beads. These include the 27kDa biotinylated N-terminal Cys EGFP and 
75kDa endogenous mammalian proteins. Lanes 1 contain one-fifth of the flow-through 
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3.2.6. Fluorescence microscopy of mammalian cells 
Fluorescence microscopy was used to visualize ECFP-expressing HEK293 cells 
labeled with the probes and to assess if the strategy could indeed be utilized for 
bioimaging applications in mammalian cells.  After transfection with pT-Rex-DEST30-
intein-ECFP-NLS constructs, cells were shown to express ECFP almost exclusively in 
their nuclei (Fig. 15A(ii)), indicating successfully nuclear localization of the protein.  
Upon further induction of intein-mediated protein cleavage to release the active N-
terminal Cys-containing ECFP, cells were labeled with TMR for 24h, washed 
extensively then visualized (Fig. 15A(iii)): the majority of the fluorescence detected in 
the TMR channel was observed to be accumulated inside the nucleus of the transfected 
cell, indicating that successful and specific labeling of the nuclear localized ECFP by 
TMR had occurred.  Finally, since ECFP and TMR form a FRET pair, the covalent 
labeling of the strategy was further confirmed by the observation of a clear FRET signal 
present exclusively in the nucleus of the labeled transfected cell (Fig. 10A(iv)).  A 
negative control with unlabeled cells expressing ECFP-NLS showed no FRET signal 
under the same exposure time (Fig 15B). 
Also apparent in the labeled cell, however, were some weaker but significant 
fluorescence signals detected at the periphery of the nucleus (Fig. 15A(iii)).  There exists 
a few probable explanations for such an observation.  Firstly, it could be caused by the 
noncovalent trapping of the probe inside the mitochondria, as rhodamine dyes and their 
derivatives (including TMR) have been known previously to localize in the mitochondria 
of mammalian cells.  In addition, the spatial orientation of the background fluorescent 
signals do seem to do point to a possible mitochondrial localization.  Secondly, it could 
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be due to the “mis-labeling” of internal cysteine residues through reversible acylation 
with the probes that have not been completely hydrolyzed (previously discussed in 
3.2.3.).  Lastly, endogenous N-terminal Cys proteins in the mammalian proteome could 
also be labeled by the thioester probes.  An extensive search of the bacterial and 
mammalian proteomes revealed very few endogenous N-terminal Cys proteins.  For 
example, a ScanProsite search on the ExPASy molecular biology server 
(http://tw.expasy.org/) of the entire E.coli proteome revealed 3 endogenous proteins with 
an N-terminal Cys residue, all of which have their cysteines involved in the active site of 
the protein molecule.  N-terminal Cys containing proteins are rare, and even if present 
inside cells, could be internally disulphide-bonded to other cysteine residues, are post-
translationally modified (e.g. N-palmitoylation, N-myristoylation, S-glycosylation etc.) or 
are involved in the active site of the protein, and are thus unavailable for reaction with 
our probes to form a stable covalent product.  A similar ScanProsite search of the Homo 
sapiens proteome revealed 10 endogenous N-terminal Cys containing proteins, 3 of 
which have their N-terminal Cys involved in the active site and 2 of which are S-
glycosylated.  It is noted however that the entire mammalian proteome has yet to be 
completed elucidated and could potentially contain more endogenous N-terminal Cys 
proteins than is currently postulated.  In spite of this, it is unlikely that the low levels of 
available N-terminal Cys endogenous proteins would contribute to significant 
background signals over the transiently expressed proteins, as the BIOTIN labeling in 
Figure 9A indicate that the great majority of labeled protein was the transiently 
overexpressed ECFP.   





























Figure 15. A) Fluorescence microscopy of N-terminal Cys ECFP-NLS-expressing 
HEK293 cells labeled with TMR for 24 h. i) phase contrast image; ii) fluorescence image 
(CFP channel), indicating nuclear localization of ECFP; iii) fluorescence image (TMR 
channel), indicating the majority of TMR labeling occurred inside the nucleus with some 
mitochondria staining; iv) FRET channel (excitation: 436 + 10 nm; emission: 620 + 30 
nm). FRET signals were detected only in the nucleus of the labeled cell. B) Fluorescence 
microscopy images of unlabeled HEK293 cells expressing N-terminal Cys ECFP-NLS. i) 
phase contrast image. ii) fluorescence microscopy image (CFP channel), showing the 
fluorescence localized to the nucleus of the cell. iii) FRET channel under the same 
exposure conditions as A(iv).  
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In this strategy where the fluorescent tag is covalently attached to the N-terminus of a 
protein, the protein effectively becomes a fluorophore itself.  In future, the signal-to-noise 
ratio of this labeling strategy may be improved or even overcome by carefully choosing 
probes which possess unique chemical, physical and biological properties. This, when 
combined with advanced bioimaging techniques such as photoactivation, FRET, 
fluorescence recovery in photobleaching (FRAP) or fluorescence loss after 
photobleaching (FLIP),[56] should make the strategy applicable to an even wider range of 
biological experiments.  
 
3.2.7. Probe toxicity 
Lastly, the cytotoxicity of the probes in mammalian cells was assessed. The biotin-
containing probe, BIOTIN, was taken as an example. Different amounts of BIOTIN 
were added to HEK293 cells transfected with ECFP-NLS, and the percentage of cell 
death as a result of BIOTIN was monitored. The percentage of cell death was determined 
for BIOTIN concentrations ranging from 100 µM to 2 mM (Fig. 16): with < 500 µM of 
BIOTIN added to the cells, minimal cell death was observed (less than 5%). With the 
addition of up to 2 mM of the probe, only ~ 20% of cell death was observed. This 
indicates that the labeling conditions (e.g. typically 10-100 µM of the probe) should have 
negligible effect on the cell viability, further validating the compatibility of this labeling 























Figure 16. Probe toxicity on HEK293 cells expressing N-terminal Cys ECFP-NLS 
proteins when labeled at different probe concentrations as determined from cell-counting 
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3.3. Protein microarray 
Interest in protein microarray technology has been growing as we passage from the 
genomic to the proteomic era.  It is becoming increasingly necessary and possible to 
complement existing techniques of gene expression profiling with chip-sized protein 
microarrays.  The main bottleneck in protein microarrays, however, is how to generate 
proteins in sufficient quantity and purity for spotting, how to immobilize them onto glass 
slides while preventing denaturation and preserving their native biological activity and 
how to detect their activity after being immobilized onto the array.  Existing methods of 
surface and immobilization chemistry remain largely non-specific while the noncovalent 
site-specific immobilization of His6-tag proteins to nickel coated slides[43] is weak and 
susceptible to a wide range of commonly used chemicals in biological assays.[58]  Intein-
mediated biotinylation of proteins for immobilization onto avidin glass slides in a site-
specific fashion have been previously described and shown to be robust and highly 
efficient.[45-48]  Using the same intein-system as described in 3.2., N-terminal Cys proteins 
were generated in vitro and in vivo and site-specifically immobilized onto thioester 
functionalized glass slides by the native chemical ligation.[47, 48]  Studies on the protein 
immobilization, detection and verification of biological activity were carried out and are 
reported in the following paragraphs.   
 
3.3.1. Spotting with purified proteins 
For spotting purposes, since only nanoliters of protein solution occupy a single spot, 
only nanogram amounts of protein are required.  Thus, although modest yields of proteins 
were obtained upon purification (i.e. 1.5mg/L), the beauty of a microarray lies in the fact 
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that only minute quantities of protein would be required for spotting and subsequent 
detection.  Purified proteins were lyophilized, followed by rehydration in PBS to an 
initial concentration of 1mg/ml and spotted onto thioester functionalized glass slides in 
decreasing concentrations.  The fluorescence scanning of arrayed spots detected with 
their respective monoclonal antibody or ligand conjugated to fluorescent dyes, revealed 
spot intensities varying in a concentration dependent fashion (Fig. 17).  The spots arrayed 
on the glass slides were generally clear and defined and with relatively low background 
signals.  This could be attributed to the extra PEG layer between the immobilized 
proteins and the glass surface which reduces non-specific binding of the antibodies to the 
slide surface.[44]  Proteins were immobilized onto the slides in a site-specific fashion and 
with no loss of native biological activity as demonstrated by the binding of glutathione 
(GSH), a natural ligand of GST (Fig. 17B).   
As observed from the native fluorescence of EGFP (Fig. 18), relative spot intensity 
reached saturation at about 0.2-1mg/ml, indicating that the upper limit of protein 
concentration for this immobilization strategy falls in this range, while the lower limit for 
protein spotting was about 0.005-0.01mg/ml.  A reasonable lower sensitivity limit for 
both the antibody and ligand-binding assay could be set around 0.01mg/ml (Fig. 17).  An 
important parameter in protein detection on an array would be the extent to which the 
probes are labeled with the fluorescent dyes.  Monoclonal antibodies and ligand were 
labeled to saturation with the fluorescent dyes to reduce the number of variables in our 
experiments.  The critical values for fluorescence detection in this microarray would 
therefore be protein concentration and probe concentration.   
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The practicability and robustness of this immobilization strategy was investigated 
through stringent washings and prolonged storage of the spotted slides.  Relative spot 
intensities (with background intensity subtracted) were measured before washing, after 
washing for 15min in PBST (0.1% Tween in PBS) and after prolonged washing in PBST 
for 2h (Fig. 18).  > 65% of N-terminal Cys protein were immobilized via the native 
chemical ligation as shown from 15min in washing in PBST; while immobilization was 
still strong under highly stringent conditions (i.e. 2h in PBST), with ~ 40% of protein 
continuing to be immobilized and fluorescing on the glass slides.  The native 
fluorescence of spotted EGFP was monitored 15 days after immobilization and storage at 
4°C.  Practically no loss of fluorescence activity was observed after this prolonged 
incubation (Fig. 19).  Taken together, these experiments demonstrate the robustness and 
versatility of the strategy for the strong covalent immobilization of proteins onto a glass 
surface, at the same time retaining the protein’s native activity and function.   
 
 
Figure 17. Immobilization and detection of purified N-terminal Cys proteins on a glass 
slide. A) N-terminal Cys EGFP spotted in varying concentrations onto a PEG-thioester 
functionalized glass slide and probed with Cy5-labeled anti-EGFP. B) N-terminal Cys 
GST spotted and incubated with Cy3-labeled GSH as a test for protein activity. Protein 
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Figure 18. N-terminal Cys EGFP immobilized onto PEG-thioester glass slide and its 
native fluorescence monitored before and after washing for different lengths of time in 
PBST. Protein concentration from left to right (mg/ml): 0.001, 0.002, 0.005, 0.01, 0.02, 
















Figure 19. Native fluorescence of N-terminal Cys EGFP monitored after protein 
immobilization and storing the slide at 4°C for 15 days. Protein concentration from left to 
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3.3.2. Spotting with crude cell lysates 
Having successfully validated the immobilization strategy with pure proteins, it was 
postulated that crude cell lysates could be directly spotted onto thioester glass slides.  The 
substantial amount N-terminal Cys proteins expressed and generated from spontaneous 
cleavage in vivo in a bacterial system (Fig. 9A) would be immobilized by native chemical 
ligation and all the unbound proteins in the cell lysates removed by simple washing.  
Crude cell lysates containing N-terminal Cys EGFP (rows 1 & 2 in Fig. 20) and N-
terminal Cys GST (row 4 in Fig. 20) were immobilized onto a thioester glass slide and 
the immobilization of these proteins detected by native EGFP fluorescence (Fig. 20B) 
and anti-GST (Fig. 20C) and GSH hybridization respectively (Fig. 20D).  The GSH 
binding assay also showed that GST proteins on the slide were still active.  To confirm 
that endogenous proteins and other overexpressed proteins not containing an N-terminal 
Cys were not immobilized nonspecifically onto the glass slides, crude lysate containing 
overexpressed EGFP not containing an N-terminal Cys (row 3 in Fig. 20), and pure GST 
without an N-terminal Cys spiked in the crude cell lysate of N-terminal Cys EGFP (row 2 
in Fig. 20) were also spotted.  These negative controls were shown to completely 
removed upon washing: the fluorescence of EGFP without N-terminal Cys disappeared 
upon washing in water (row 3 in Fig. 20A & B); while no GST in the spiked sample was 
detected upon anti-GST and GSH hybridization (row 2 in Fig. 20C & D respectively).   
 
























Figure 20. Direct spotting of whole cell lysates containing N-terminal Cys proteins and 
negative controls onto thioester functionalized glass slides and subsequent detection. The 
same protein concentration is spotted in triplicates horizontally in a decreasing fashion. 
Row 1: N-terminal Cys EGFP, 2: N-terminal Cys EGFP spiked with pure GST (1mg/ml, 
no N-terminal Cys), 3: EGFP without N-terminal Cys, 4: N-terminal Cys GST. A) 
Prewash visualized in FITC channel; B) After washing with water visualized in FITC 
channel; C) Hybridization with GSH-Cy3 visualized in Cy3 channel; D) Hybridization 
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As the N-terminal domain of a fusion protein determines expression level, the 
advantage of having a highly soluble and well-expressed intein at the N-terminal is that 
the expression of typically poorly expressed proteins are boosted.  Some potential 
limitations of this system include the formation inclusion bodies in a bacterial system 
which would involve the tedious process of denaturation and subsequent protein 
refolding.  Secondly, proteins with their N-terminus deeply buried within the molecule 
would not have a freely available N-terminal Cys residue to react with the thioester 
groups on the glass slides.  This could be overcome by adding additional sequences to 
create a longer linker between the first amino acid of the protein and the N-terminal Cys.  
One of the major stumbling blocks in current protein microarray technology is that 
proteins tend to denature on a glass slide and lose their biological activity on prolonged 
storage.  This novel microarray promises to overcome the problem of denaturation, with 
proteins retaining their biological activity for a relatively long period of time (Fig. 15), 
presumably due to site-specific immobilization of the proteins.  It is noted, however, that 
different proteins would clearly have different stabilities and would hence require 
different conditions for them to remain fully active. 
This method has the following advantages over previously reported strategies used in 
the generation of proteome chips: 1) site-specific immobilization allows the proteins to 
retain their full biological activities as the proteins are oriented uniformly away from the 
surface with their active sites readily available for interactions with other proteins, 
ligands, small molecules etc. 2) the generation of N-terminal Cys proteins is direct and 
facile using the intein-mediated system, and 3) the system is extremely robust as proteins 
are attached onto glass slides by means of a  strong covalent bond as compared to weak 
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non-covalent interactions.  This novel protein array proposes a direct and robust means 
for the high-throughput functional profiling of thousands of proteins and eventually the 
entire proteome of any organism for novel protein functions, protein-protein interactions, 
protein-ligand partners etc. in a single glass slide.   
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4. Conclusion  
Our labeling approach has several advantages over existing strategies.[8, 14, 19, 20-30]  
Genetic fusions require the introduction of a macromolecular protein, namely GFP (27 
kDa, or its derivatives),[20-22] avidin (55 kDa),[26] hAGT (21 kDa),[28] or DHFR (18 
kDa)[29] to the target protein, which may subsequently affect its biological and cellular 
activities.  In our strategy, only one extra amino acid, i.e. cysteine, is introduced, thus 
minimizing potential perturbation to the original conformation and activity of the protein.  
This also compares well with the biarsenical approach which requires the presence of a 
CCXXCC located in an α-helix of the target protein.[23]  Since N-terminal Cys-containing 
proteins could be readily generated in vivo,[51-55] our approach does not require complex 
genetic manipulation of the protein/host.[19]  Lastly, with the easy access to potentially a 
large array of thioester-containing small molecule probes, our approach may provide a 
highly general method for in vivo protein labeling in a variety of biological experiments.   
In conclusion, we have developed a simple yet highly versatile method for site-
specific, covalent labeling of proteins inside live cells.  We have shown that this strategy 
can be applied to different organisms with tolerable background labeling and with a 
variety of easily accessible small molecule probes, thus making it potentially useful for 
future bioimaging and proteomics applications. 
Using the same strategy for protein microarray generation, we have presented a facile 
and robust method to generate proteins for site-specific immobilization in an array 
format, while preserving the biological activity of the protein in the process.  In order to 
fully realize the tremendous potential of protein and peptide microarrays, there is an 
urgent need to develop strategies that allow site-specific and stable immobilization of 
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proteins, peptides and other biomolecules onto a glass surface such that their native 
biological activities are fully retained.  The past few years have witnessed an increasing 
number of reports that address this critical issue.  It must be noted that only when 
combining immobilization strategies with improved arraying devices, labeling reagents, 
detection devices and data analysis tool, can the potential of microarrays be demonstrated 
to their fullest. 
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